ENTO has been in the news 346% more than usual
May 01, 2025, 4:32 PM
18.59%
What does ENTO do
First Wave Biopharma, headquartered in Boca Raton, Florida, develops nonsystemic therapies for gastrointestinal diseases and went public in October 2016. Its key programs include latiglutenase, capeserod, and adrulipase.
ENTO has been in the news recently: Rosen Law Firm and The Gross Law Firm are urging Zenas BioPharma investors to join a class action lawsuit by June 16, 2025, over allegations of misleading statements. Additionally, Simtra BioPharma Solutions released its inaugural Sustainability Report for 2024, showcasing a 51% waste recycling rate and a 26% increase in employee growth.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.